Tian An Medicare Limited (HKG:0383)
Hong Kong
· Delayed Price · Currency is HKD 0.8000
0.00 (0.00%)
Jun 12, 2025, 3:51 PM HKT
Tian An Medicare Revenue
In the year 2024, Tian An Medicare had annual revenue of 1.63B HKD with 3.72% growth. Tian An Medicare had revenue of 805.67M in the half year ending December 31, 2024, with 14.79% growth.
Revenue
1.63B
Revenue Growth
+3.72%
P/S Ratio
0.53
Revenue / Employee
619.65K
Employees
2,626
Market Cap
866.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.63B | 58.38M | 3.72% |
| Dec 31, 2023 | 1.57B | 130.96M | 9.11% |
| Dec 31, 2022 | 1.44B | -25.63M | -1.75% |
| Dec 31, 2021 | 1.46B | 269.35M | 22.56% |
| Dec 31, 2020 | 1.19B | -33.42M | -2.72% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |